Prohibition Partners · Free weekly briefing
International Cannabis Weekly
The week’s global cannabis news, read through the analyst’s lens — one sentence per story, sourced.
375
6 regions29 stories14 countries
Top story
Juicy Fields ring leaders finally face trial 2 years after collapse
Leaders of the now notorious cannabis investment scam Juicy Fields are finally being brought to justice, two years after the company collapsed and hundreds of millions of investors money were lost.
Business & Investmentlink no longer available
- 01
Italy plans to restrict nascent 'cannabis light' industry
ITRegulationlink no longer available
- 02
Billions wiped off U.S. cannabis firms' market value amid mixed Q3 results
USBusiness & Investmentlink no longer available
Europe
6 stories- What the collapse of Germany's government means for the cannabis industry
DERegulationlink no longer available
- Polish lawmakers send marijuana decriminalisation petition to prime minister
PLRegulationlink no longer available
- French parliamentary group La France Insoumise proposes legalisation by 2025
FRRegulationlink no longer available
- EU starting preparations to supply medical cannabis to Ukraine
EUUAMedicallink no longer available
- Spain's medical cannabis market: why the long-awaited rollout remains uncertain
ESMedicallink no longer available
- UK government panel recommends raising THC limit in hemp
GBHemp & CBDlink no longer available
United States
6 stories- Newly elected Republican senate majority leader opposes cannabis legalisation
USRegulationlink no longer available
- Federal agency grants US$8.4 million for sustainable alternatives
USHemp & CBDlink no longer available
- Top Pennsylvania health official blocks medical cannabis recommendation proposals
USMedicallink no longer available
- Ohio retailers sell more than US$131 million worth of adult-use cannabis
USAdult-uselink no longer available
- Torch lights a promising path to Delta-9 beverages for retailers and consumers
USBusiness & Investmentlink no longer available
- Eaze secures US$10 million to reopen 70 stores after collapse
USBusiness & Investmentlink no longer available
Canada
7 stories- Majority of Canadians buy all cannabis products from legal sellers
CAAdult-uselink no longer available
- Cronos sales jump 38% as Spinach secures top spots in market
CABusiness & Investmentlink no longer available
- Canopy Growth announces second-quarter financial results for fiscal 2025
CABusiness & Investmentlink no longer available
- Canada's TerrAscend set to expand into Ohio cannabis market
CAUSBusiness & Investmentlink no longer available
- Noya Holdings and Noya Cannabis file for creditor protection
CABusiness & Investmentlink no longer available
- MediPharm Labs schedules release date for third-quarter 2024 results
CABusiness & Investmentlink no longer available
- Canadian cannabis exports to Israel could face tax rates up to 175%
CAILBusiness & Investmentlink no longer available
LATAM & Caribbean
4 stories- New project offers free cannabis treatment to support children with autism
Medicallink no longer available
- Veterinary prescription of cannabis-based products added to official gazette
Medicallink no longer available
- MisioPharma wants to increase cannabis oil production by importing CBD
Business & Investmentlink no longer available
- Costa Rica legalises self-cultivation of cannabis for personal use
CRAdult-uselink no longer available
Africa & Middle East
1 story- South Africa advances cannabis decriminalisation efforts for legal reform
ZARegulationlink no longer available
Oceania
2 stories- Federal Parliament in Australia to vote on Greens' legalisation bill
AURegulationlink no longer available
- Study finds New Zealand cannabis users consuming less alcohol
NZHealth & Sciencelink no longer available
Never miss an issue
International Cannabis Weekly in your inbox every week — the global developments that move the market, with the data behind them.
From the research library
Global Medical Cannabis Market Review
14 key international markets, 2025–2030. Sizing, forecasts and regulatory outlook.
From £1,265
View report